NSE - Delayed Quote INR

Divi's Laboratories Limited (DIVISLAB.NS)

5,640.00

-114.00

(-1.98%)

At close: April 17 at 3:29:58 PM GMT+5:30

Divi's Laboratories Ltd (BOM:532488) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ...

Divi's Laboratories Ltd (BOM:532488) reports robust financial performance and strategic advancements amid industry challenges.

GuruFocus.com 2 months ago

DIVISLAB.NS
-1.98%
India's Divi's Labs beats Q3 profit estimates on strong API demand; shares rise

India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used in drugs, sending its shares higher. The company's consolidated net profit jumped 64.5% to 5.89 billion rupees ($67.6 million) in the third quarter, slightly above analysts' estimates of 5.13 billion rupees, as per LSEG data. Divi's is one of India's largest manufacturers of active pharmaceutical ingredients (API), key components of a drug that produce the intended therapeutic effects.

Reuters 2 months ago

DIVISLAB.NS
-1.98%
Divi's Laboratories Ltd (BOM:532488) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst ...

Discover how Divi's Laboratories Ltd (BOM:532488) is balancing significant revenue growth with pricing pressures and logistical hurdles in its latest earnings call.

GuruFocus.com 5 months ago

DIVISLAB.NS
-1.98%
How to invest in the Indian stock market

India’s stock market capitalisation topped $4.3tn to overtake Hong Kong as the world’s fourth-largest market.

Yahoo Finance UK 5 months ago

TAJGVK.NS

HSBC

CELLO.NS

Performance Overview

Return	DIVISLAB.NS	S&P BSE SENSEX (^BSESN)
YTD	-7.52%	+0.53%
1-Year	+50.75%	+7.69%
3-Year	+29.15%	+34.65%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Divi's Laboratories Limited (DIVISLAB.NS)

Divi's Laboratories Ltd (BOM:532488) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ...

India's Divi's Labs beats Q3 profit estimates on strong API demand; shares rise

Divi's Laboratories Ltd (BOM:532488) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst ...

How to invest in the Indian stock market

Performance Overview